Maximum quantity allowed is 999
CAS RN: 27848-84-6 | Product Number: N0904
Nicergoline
Purity: >98.0%(T)(HPLC)
- [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl 5-Bromopyridine-3-carboxylate
- 5-Bromopyridine-3-carboxylic Acid [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl Ester
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | N0904 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__4H__2__6BrN__3O__3 = 484.39 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Light Sensitive,Heat Sensitive |
Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image), 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 27848-84-6 |
| Reaxys Registry Number | 903548 |
| PubChem Substance ID | 135727224 |
| Merck Index (14) | 9496 |
| MDL Number | MFCD00869626 |
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 134.0 to 138.0 °C |
| Specific rotation [a]20/D | +5.2 to +6.2 deg(C=5, EtOH(95vol%)) |
| Melting Point | 136 °C |
| Specific Rotation | 6.0° (C=5,EtOH(95vol%)) |
| Solubility (soluble in) | Ethanol |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
| RTECS# | KE6341000 |
| H.S.code* | 2933.99-000 |
References
- Nicergoline inhibits T-type calcium channels in rat isolated hippocampal CA1 pyramidal neurons
- K. Takahashi, N. Akaike, Br. J. Pharmacol. 1990, 100, 705.
- Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged
- Cholinergic deficits in aged rat brain are corrected with nicergoline
- Pharmacological study of nicergoline. Effects on regional cerebral blood flows and arterial carbon dioxide and oxygen pressure and pH in rats under cyanide-induced histotoxic anoxia
- K. Shintomi, Arzneim.-Forsch. 1991, 41, 885.
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.